Back
InMed Pharmaceuticals Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
32
INM
InMed Pharmaceuticals
Last Price:
4.56
Seasonality Move:
17.03%
Buy
68
AUPH
Aurinia Pharmaceuticals
Last Price:
8.77
Seasonality Move:
24.51%
Sell
32
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy, Sell or Hold?
- The current InMed Pharmaceuticals [INM] share price is $4.23. The Score for INM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- INM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.77. The Score for AUPH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INM Stock Price Chart
What is InMed Pharmaceuticals's stock price today?
-
The InMed Pharmaceuticals share price today is $4.23
The current trend is moderately bearish and INM is experiencing slight buying pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
INM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.37 | Buy |
Relative Strength Index (14 RSI): | 41.58 | Sell |
Chaikin Money Flow: | 3416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 71.82 | Buy |
Chaikin Money Flow: | 1867716 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.13 - 8.27) | Buy |
Bollinger Bands (100): | (5.79 - 7.57) | Buy |
INM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.93 | Sell |
20-day SMA: | 6.13 | Sell |
50-day SMA: | 2.6 | Buy |
200-day SMA: | 0.87 | Buy |
8-day EMA: | 11.04 | Sell |
20-day EMA: | 8.05 | Sell |
50-day EMA: | 4.24 | Sell |
200-day EMA: | 1.56 | Buy |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.28 | Buy |
20-day SMA: | 7.86 | Buy |
50-day SMA: | 7.38 | Buy |
200-day SMA: | 6.09 | Buy |
8-day EMA: | 8.28 | Buy |
20-day EMA: | 7.95 | Buy |
50-day EMA: | 7.43 | Buy |
200-day EMA: | 6.82 | Buy |
InMed Pharmaceuticals Earnings Growth & INM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
InMed Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |